Here's A Approach That Is Even Aiding Fluconazole-Masters To Improve

Матеріал з HistoryPedia
Версія від 07:17, 10 грудня 2016, створена Shovel9perch (обговореннявнесок) (Створена сторінка: .. [http://en.wikipedia.org/wiki/Fluconazole Fluconazole] To more directly investigate S-type anion channel regulation in planta, we established slac1-1 plant l...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

.. Fluconazole To more directly investigate S-type anion channel regulation in planta, we established slac1-1 plant lines which express SLAC1 WT, S59A, S120A, and S59A/S120A fused to mVenus under the native SLAC1 promoter and carried out patch clamp analyses. Expression of wildtype SLAC1-mVenus in slac1-1 guard cells resulted in recovery of S-type anion channels (Figure 6G and Figure 6��figure supplement 3A). Unexpectedly, expression of the single site SLAC1 mutants, SLAC1 S59A or SLAC1 S120A in slac1-1 guard cells restored ABA regulation of S-type anion currents (Figure 6G and Figure 6��figure supplement 3A). However, expression of the double phosphorylation site SLAC1 mutant, SLAC1 S59A/S120A did http://www.selleckchem.com/products/Paclitaxel(Taxol).html not restore ABA activation of S-type anion channels (Figure 6G and Figure 6��figure supplement 3A). Furthermore, ABA-induced stomatal closing responses in these complementation lines confirmed the need to mutate both the S59 and S120 sites to alanine to significantly impair ABA-induced stomatal closing in planta (Figure 6H and Figure 6��figure supplement 3B). The above described patch clamp and stomatal movement experiments were conducted with two independent complementation lines (Figure 6G,H and Figure 6��figure supplement 3A,B). To ensure that the impaired ABA-activation of S-type anion currents and stomatal closure in the SLAC1 S59A/S120A mutant was not due to non-expressed protein we investigated the mVenus-derived fluorescence in all complementation lines. All SLAC1 complementation lines expressed SLAC1-mVenus driven by the native SLAC1 promoter to a similar degree (Figure 6��figure supplement 4). We examined putative roles of the two phosphorylation sites in SLAC1 for interaction of SLAC1 with CPK6 and ABI1 by BiFC analysis. Reconstituted YFP fluorescence intensity of CPK6-YN co-expressed with YC-SLAC1-S59A, YC-SLAC1-S120A, or YC-SLAC1-S59A/S120A was significantly lower than that of CPK6-YN co-expressed with YC-SLAC1-WT (Figure 6��figure supplement 5). YN-ABI1 co-expression with the YC-SLAC1-S59A mutant did not significantly change the YFP fluorescence intensity while BGJ398 concentration YN-ABI1 co-expression with YC-SLAC1-S120A or YC-SLAC1-S59A/S120A resulted in lower YFP fluorescence intensity when compared to YN-ABI1 co-expression with YC-SLAC1-WT (p